1. behalf of Groupe Francais d'Etuide de la Fetrahvdroaminoacridine. TIacrine tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial;Chatellier, G.; on, Lacomblez Z.;frM _dJ,1990
2. A double-blind placebo-controlled trial of high-dose lecithin in Alzheimer's disease;Little, A.; Lesy, R.; P', Chuaqui-Kidd; Hand, D.;7 Neurol Neurosurg Pssschtatrv,1985
3. Oral tetrahydroaminoacridine in long-term treatment of senile dementia;Summers, W.K.; Majowski, L.V.; Marsh, G.M.I.; Tachiki, K.; Kling, A.,1986
4. Biological and neuropsychological characterisation of physostigmine and nonresponders in Alzheimer's disease;Harrell, L.E.; Jope, R.S.; Falgout, J.;J Am Geriatr Soc,1990
5. Statistical ptrwer analvsis Jor the behavioral sciences;Cohen, J.,1988